Kelly Kucharczyk

Principal Consultant, Project Medtech

Kelly Kucharczyk is a Principal Consultant who partners with startups to help navigate the complexities of medical device development, with a strong passion for developing commercialization strategies that look across regulatory, reimbursement, and clinical to align with the overarching business objective. She serves as a strategic ally helping companies intentionally scale for sustainable growth or position for a successful exit.

With extensive expertise in global market entry and FDA negotiations, Kelly is experienced in building "acquisition-ready" Quality Management Systems (QMS) and Design History Files (DHF). Her leadership background includes serving as a Director at NAMSA, where she guided global teams across Regulatory, Quality, and Medical Writing. Prior to this, Kelly spent nearly a decade at Stryker, driving regulatory strategies for new product development and managing complex M&A activities from initial due diligence through full post-acquisition integration.

Outside of the Medtech world, she is an outdoor enthusiast and avid gardener who can frequently be found foraging for wild foods, experimenting with new recipes in the kitchen, or collaborating on "toddler art" masterpieces.

Event

1:45 PM end time not listed

StartupCincyPanel

Nobody Moves a Biotech Startup to Kentucky... Until They Do

Location not listed

Christin Godale, Kelly Kucharczyk and 1 more

Health & Life Sciences

Details

Led by Project MedTech, this discussion explores why a growing number of life sciences founders are choosing Cincinnati and Northern Kentucky to launch, relocate, and scale their companies.

While biotech is often associated with Boston, San Diego, and the Bay Area, innovative companies are increasingly finding advantages in emerging ecosystems that offer access to talent, infrastructure, strategic partnerships, and a collaborative startup community. Through a conversation with leaders from LifeSciKY, CARTx Therapeutics, and Clareo Biosciences, attendees will hear firsthand how founders evaluate where to build their companies, the challenges they face, and what resources have been critical to their success.

This session will provide founders, investors, students, and ecosystem builders with a candid look at the realities of building a high-growth life sciences startup in the Midwest and why the region is becoming a destination for innovation.

Also with Melissa Smith

Source: startupcincyweek.com (opens in a new tab)

All people